# Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment

> **NCT04698174** · NA · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 39 (actual)

## Conditions studied

- Ametropia

## Interventions

- **PROCEDURE:** Transepithelial Photorefractive keratectomy (tPRK) without laser polishing
- **PROCEDURE:** Transepithelial Photorefractive keratectomy (tPRK) with laser polishing
- **PROCEDURE:** Standard Photorefractive keratectomy (PRK)

## Key facts

- **NCT ID:** NCT04698174
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-02
- **Primary completion:** 2022-03-21
- **Final completion:** 2022-03-21
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698174, "Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04698174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*